U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07315282) titled 'The Effect of Oral Iron Supplements on Insulin and Glucose Metabolism in Overweight and Obese Women' on Dec. 18, 2025.
Brief Summary: The study will be a randomized, double-blind, 17-day metabolic intervention trial including 14 days of high-dose or low-dose iron supplementation. A total of 70 overweight or obese (OW/OB) women will be enrolled. Participants will be individually randomized into either the high-iron or low-iron group.
Women in the low-iron group will receive 15 mg of iron as ferrous fumarate daily for 14 days, while women in the high-iron group will receive 195 mg of iron as ferrous sulfate daily for 14 days.
The stu...